Middle East conflict may hit India’s exports beyond region if prolonged, says government
A prolonged conflict in Middle East could begin to hurt India’s exports not just to the region but…
Sanofi CEO: The enterprise AI shift will reshape pharma in 2026
Paul Hudson has been CEO of Sanofi since September 2019. Previously, he was CEO of Novartis Pharmaceuticals from…
Dr Reddy’s to leverage its products in US, European markets for growth in India, emerging markets
The Indian pharmaceutical industry is undergoing some challenges in the form of pricing pressure in the US market…
Pfizer’s Drug Price Cuts Yield Three-Year Trump Tariff Reprieve
(Bloomberg) — Pfizer Inc. secured a reprieve from President Donald Trump’s long-threatened tariffs on the pharmaceutical industry Tuesday…
All bark, no bite: Trump’s latest trade war turns into another TACO salad for Wall Street
When President Donald Trump made his “Liberation Day” speech on April 2, announcing sweeping tariffs across a range…
AI drug companies are struggling—but don’t blame the AI
Moonshot hopes of artificial intelligence being used to expedite the development of drugs are coming back down to…
Impact of US tariffs varies across European Union | News
European countries are not all equally exposed to the US market and so will not suffer the same…
From ‘mushroom murders’ to safe foraging: The risks and rewards of wild mushrooms • FRANCE 24
From ‘mushroom murders’ to safe foraging: The risks and rewards of wild mushrooms • FRANCE 24 It’s time…
Japan’s Oldest Pharma Firm to Be Sold to Bain Capital
Mitsubishi Tanabe Pharma, Japan’s oldest pharmaceutical company with a 350-year history, is approaching a major turning point. Its…
Denmark raises 2025 GDP outlook, benefits from Novo Nordisk’s growth
COPENHAGEN (Reuters) – Denmark has again raised its outlook for economic growth, fuelled by the expansion of the…
Danish town where Ozempic is made has highest rates of overweight children in Denmark
Novo Nordisk has become Europe’s most valuable company due to soaring demand for its weight-loss-aiding drugs Wegovy, Semaglutide,…
Sanofi pursues sale of France’s leading painkiller to US investment fund after controversy
Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment…